This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gros, L. Articles by Piechaczyk, M. Search for Related Content PubMed PubMed Citation Articles by Gros, L. Articles by Piechaczyk, M.

 Previous Article  |  Next Article 

Journal of Virology, October 2006, p. 10191-10200, Vol. 80, No. 20
0022-538X/06/$08.00+0     doi:10.1128/JVI.01095-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Efficient Mother-to-Child Transfer of Antiretroviral Immunity in the Context of Preclinical Monoclonal Antibody-Based Immunotherapy

Laurent Gros,^* Mireia Pelegrin, Marc Plays, and Marc Piechaczyk

Institut de Génétique Moléculaire de Montpellier, UMR 5535-IFR 122, CNRS, 1919, Route de Mende, 34293 Montpellier Cedex 5, France

Received 29 May 2006/ Accepted 24 July 2006

When mice under the age of 5 to 6 days are infected, the FrCas^E retrovirus induces a neurodegenerative disease leading to death within 1 to 2 months. We have recently reported that transient treatment with a neutralizing monoclonal antibody (MAb) shortly after infection, in addition to an expected immediate decrease in the viral load, also favors the development of a strong protective immune response that persists long after the MAb has been cleared. This observation may have important therapeutic consequences, as it suggests that MAbs might be used, not only as direct neutralizing agents, but also as immunomodulatory agents enabling patients to mount their own antiviral immune responses. We have investigated whether immunoglobulins from mothers who displayed a strong anti-FrCas^E humoral response induced upon MAb treatment could affect both viremia and the immune systems of FrCas^E-infected pups till adult age upon placental and/or breastfeeding transfer. The strongest effects, i.e., reduction in the viral load and induction of protective humoral antiviral responses, were observed upon breastfeeding alone and breastfeeding plus placental immunity transfer. However, placental transfer of anti-FrCas^E antibodies was sufficient to both protect neonatally infected animals and help them initiate a neutralizing anti-FrCas^E response. Also, administration of a neutralizing MAb to naive mothers during late gestation and breastfeeding could generate similar effects. Taken together, our data support the concept that passive immunotherapies during late gestation and/or breastfeeding might help retrovirally infected neonates prime their own protective immune responses, in addition to exerting an immediate antiviral effect.

---

* Corresponding author. Mailing address: Institut de Génétique Moléculaire de Montpellier, UMR 5535-IFR 122, CNRS, 1919, Route de Mende, 34293 Montpellier Cedex 5, France. Phone: (33) 4 67 61 36 71. Fax: (33) 4 67 04 02 31. E-mail: laurent.gros{at}igmm.cnrs.fr.

---

Journal of Virology, October 2006, p. 10191-10200, Vol. 80, No. 20
0022-538X/06/$08.00+0     doi:10.1128/JVI.01095-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Gros, L., Pelegrin, M., Michaud, H.-A., Bianco, S., Hernandez, J., Jacquet, C., Piechaczyk, M. (2008). Endogenous Cytotoxic T-Cell Response Contributes to the Long-Term Antiretroviral Protection Induced by a Short Period of Antibody-Based Immunotherapy of Neonatally Infected Mice. J. Virol. 82: 1339-1349 [Abstract] [Full Text]